Literature DB >> 35721298

Prevalence of lichen planopilaris in the United States: A cross-sectional study of the All of Us research program.

Tejas P Joshi1, Harrison Zhu1, Zain Naqvi1, Swathi Holla1, Anthony Duruewuru1, Vicky Ren2.   

Abstract

Entities:  

Keywords:  epidemiology; hair loss; lichen planopilaris; lichen planus; prevalence

Year:  2022        PMID: 35721298      PMCID: PMC9204717          DOI: 10.1016/j.jdin.2022.05.003

Source DB:  PubMed          Journal:  JAAD Int        ISSN: 2666-3287


× No keyword cloud information.
To the Editor: Lichen planopilaris (LPP) is a variant of lichen planus characterized by follicular hyperkeratosis and T-lymphocyte mediated perifollicular inflammation that often progresses to irreversible, scarring alopecia. There is a paucity of epidemiological data on LPP, with current estimates of LPP prevalence being based on single-center and single-city studies.1, 2, 3, 4 There are no studies that evaluate LPP prevalence in a diverse, nationwide cohort of American patients. Here, we aimed to estimate the prevalence of LPP using the All of Us database, a recently launched initiative by the National Institutes of Health that strives to include communities that have been historically underrepresented in research. We performed a cross-sectional analysis in All of Us and identified LPP cases using International Classification of Diseases, Tenth Revision, Clinical Modification code L66.1 and SNOMED code 64540004. Participants’ age, ethnicity, race, and sex were extracted from electronic medical records. The overall prevalence and prevalence within each age and racial/ethnic group were calculated using the Wald method with 95% CIs. As of March 2022, All of Us has enrolled 327,654 participants. We identified 142 individuals with LPP, representing an overall prevalence of 0.043% (95% CI, 0.042-0.044). The average age at diagnosis was 62.4 years (SD, 11.2 years). The prevalence was highest in the 65-74 year age group (0.091%; 95% CI, 0.088-0.093), followed by the 55 to 64 year age group (0.054%; 95% CI, 0.052-0.055). Females constituted 91.6% of the LPP population. Prevalence in specific racial groups included 0.009% (95% CI, 0.007-0.011) in Asian, 0.029% (95% CI, 0.028-0.030) in Black, 0.021% (95% CI, 0.020-0.023) in Hispanic, and 0.057% (95% CI, 0.019-0.021) in White participants (Table I). Altogether, the majority of LPP cases were over the age of 55 years and self-identified as White (Fig 1).
Table I

Prevalence of lichen planopilaris in All of Us across age and racial/ethnic groups

GroupTotal population, nLPP cases, nPrevalence, % (95% CI)Female, n (%)
Overall327,6541420.043 (0.042-0.044)129 (91.6)
Age group, y
 <45111,61890.008 (0.008-0.009)7 (77.8)
 45-5451,047230.045 (0.043-0.047)21 (91.3)
 55-6469,141370.054 (0.052-0.055)32 (86.5)
 65-7464,072580.091 (0.088-0.093)53 (91.4)
 74+36,480150.041 (0.039-0.043)15 (100.0)
Racial/ethnic group
 Asian11,04010.009 (0.007-0.011)0 (0)
 Black69,087200.029 (0.028-0.030)18 (90.0)
 Hispanic60,540120.020 (0.019-0.021)12 (100.0)
 White177,6471010.057 (0.056-0.058)93 (92.1)

LPP, Lichen planopilaris.

Fig 1

Distribution of lichen planopilaris cases by age group.

Prevalence of lichen planopilaris in All of Us across age and racial/ethnic groups LPP, Lichen planopilaris. Distribution of lichen planopilaris cases by age group. We show that LPP is most prevalent in women over the age of 55 years, a finding consistent with previous studies.2, 3, 4 In addition, we note LPP to be most prevalent among Whites, supporting the study by Trager et al. However, our prevalence estimate of 0.043% is higher than the 0.017% prevalence reported by Trager et al. Our analysis is subject to limitations. We base our identification of LPP cases on billing codes and are unable to confirm the diagnosis of LPP via histopathology reports. Additionally, older adults are overrepresented in All of Us, skewing the age distribution toward the 55 to 64 and 65 to 75 year age groups. Moreover, the diagnosis of hair disorders (in comparison to skin diseases) is often delayed, affecting the age at which diagnosis is thought to be most prevalent. Hair disorders may also be underdiagnosed in patients with skin of color; thus, the actual prevalence of LPP in patients with skin of color may be higher than the estimates we provide. Additional studies utilizing a national registry or a large insurance claims database would be helpful in further characterizing LPP prevalence in the United States.

Conflicts of interest

None disclosed.
  5 in total

1.  Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York City health care system.

Authors:  Megan H Trager; Jonathan Lavian; Eunice Y Lee; Dahsan Gary; Fabian Jenkins; Angela M Christiano; Lindsey A Bordone
Journal:  J Am Acad Dermatol       Date:  2020-10-31       Impact factor: 11.527

2.  Lichen planopilaris: clinical and pathologic study of forty-five patients.

Authors:  D A Mehregan; H M Van Hale; S A Muller
Journal:  J Am Acad Dermatol       Date:  1992-12       Impact factor: 11.527

3.  Lichen planopilaris: Epidemiology and prevalence of subtypes - a retrospective analysis in 104 patients.

Authors:  Johanna Meinhard; Andrea Stroux; Lena Lünnemann; Annika Vogt; Ulrike Blume-Peytavi
Journal:  J Dtsch Dermatol Ges       Date:  2014-02-17       Impact factor: 5.584

4.  Primary cicatricial alopecias: clinicopathology of 112 cases.

Authors:  Eileen Tan; Magdalena Martinka; Nigel Ball; Jerry Shapiro
Journal:  J Am Acad Dermatol       Date:  2004-01       Impact factor: 11.527

5.  The "All of Us" Research Program.

Authors:  Joshua C Denny; Joni L Rutter; David B Goldstein; Anthony Philippakis; Jordan W Smoller; Gwynne Jenkins; Eric Dishman
Journal:  N Engl J Med       Date:  2019-08-15       Impact factor: 176.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.